Pharm Exec4h
FDA Approves AstraZeneca, Daiichi Sankyo’s Datroway for Previously Untreated Unresectable, Metastatic HR-Positive, HER2-Negative Breast Cancer
Approval is based on results from the TROPION-Breast01 Phase III trial, in which Datroway demonstrated a significant reduction in the risk of disease progression or death in patients with previously ...
Hosted on MSN11h
‘30 days to live’: Laredo’s Ruben Vela reflects on journey from dire diagnosis to cancer-free
Life changed abruptly for United ISD employee Ruben Vela in June 2019 when he received a dire diagnosis he never imagined — he had pancreatic cancer. His journey from diagnosis to survival has been ...
bodyandsoul.com.au18h
Women under 50 are 82% more likely to get cancer than men
Despite rates of cancer dropping in the last few years, women in the US are significantly more likely to be diagnosed than men. A doctor from Northwell Health Cancer Institute breaks down some ...